Dx4Life Addresses Overwhelming Interest in IVF Test

Dx4Life, a company pioneering personalized diagnostics for In Vitro Fertilization (IVF), has expressed profound gratitude for the significant public response following recent news of its clinical study. The study demonstrated the effectiveness of their novel oral swab test in improving IVF success rates by guiding optimal hormone treatment.

The company acknowledges a heartfelt wave of inquiries from couples eager to access the test. "We are beyond grateful for the response we've received regarding our clinical study," stated Professor Yvonne Lundberg Giwercman, CEO of Dx4Life. "To all the couples that have reached out, it breaks our hearts that we're not able to provide the test yet."

Dx4Life is actively working towards making the test commercially available. The current projection is for the test to receive CE-marking and ISO-certification to become available in early 2026.

---

Want to recieve updates and be notified when Dx4Life's test is launched?

We are beyond grateful to all of you who already signed up to our waitlist.

If you want to join, please sign up here: Home

---

For those interested in understanding the mechanics of the test, a video demonstration by Swedish public broadcaster SVT provides a visual explanation. The segment, which is in Swedish, can be viewed at: https://www.svt.se/nyheter/lokalt/skane/svabbtest-i-munnen-kan-ge-fler-barn-hjalper-ofrivilligt-barnlosa.